avapro and Hypoxia
avapro has been researched along with Hypoxia in 3 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "ARB prevents chronic sleep apnea-enhanced cardiac apoptosis via enhancing survival pathways." | 1.72 | Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation. ( Huang, CY; Lee, SD; Lin, CY; Lin, YY; Liou, YF; Pai, PY; Wong, JKS; Wu, XB; Yu, SH, 2022) |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Pai, PY | 1 |
| Lin, YY | 1 |
| Yu, SH | 1 |
| Lin, CY | 1 |
| Liou, YF | 1 |
| Wu, XB | 1 |
| Wong, JKS | 1 |
| Huang, CY | 1 |
| Lee, SD | 1 |
| Boccellino, M | 1 |
| Di Domenico, M | 1 |
| Donniacuo, M | 1 |
| Bitti, G | 1 |
| Gritti, G | 1 |
| Ambrosio, P | 1 |
| Quagliuolo, L | 1 |
| Rinaldi, B | 1 |
| Rakusan, K | 1 |
| Chvojkova, Z | 1 |
| Oliviero, P | 1 |
| Ostadalova, I | 1 |
| Kolar, F | 1 |
| Chassagne, C | 1 |
| Samuel, JL | 1 |
| Ostadal, B | 1 |
Other Studies
3 other studies available for avapro and Hypoxia
| Article | Year |
|---|---|
Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Hypo | 2022 |
AT1-receptor blockade: Protective effects of irbesartan in cardiomyocytes under hypoxic stress.
Topics: Animals; Cardiovascular Diseases; Catalase; Gene Expression Regulation; Heart Injuries; Humans; Hypo | 2018 |
ANG II type 1 receptor antagonist irbesartan inhibits coronary angiogenesis stimulated by chronic intermittent hypoxia in neonatal rats.
Topics: Altitude; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Arterioles; Biphenyl C | 2007 |